Article Details
Retrieved on: 2022-09-23 08:34:27
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The European Commission ((EC)) approved the expanded use of AstraZeneca's (AZN) Ultomiris (ravulizumab) as an add-on to standard therapy for adult ...
Article found on: seekingalpha.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here